Michael M. Strage
Founder at ANGIOGENEX, INC.
Profile
Michael M.
Strage is the founder.
In 1996, he founded Axonyx, Inc. where he held the title of Chief Administrative Officer & Vice President.
In 1999, he founded AngioGenex, Inc. where he holds the titles of Chief Operations Officer, Director & VP.
He also worked as an Associate at Hancock Rothert & Bunshoft LLP.
Michael M. Strage active positions
Companies | Position | Start |
---|---|---|
ANGIOGENEX, INC. | Founder | 1999-03-30 |
Former positions of Michael M. Strage
Companies | Position | End |
---|---|---|
Hancock Rothert & Bunshoft LLP
Hancock Rothert & Bunshoft LLP Miscellaneous Commercial ServicesCommercial Services Part of Duane Morris LLP, Hancock Rothert & Bunshoft LLP is a legal advisory services provider. The private company is based in Los Angeles, CA. Hancock Rothert & Bunshoft was acquired by Duane Morris LLP on January 01, 2006. | Corporate Officer/Principal | - |
Axonyx, Inc.
Axonyx, Inc. Pharmaceuticals: MajorHealth Technology Axonyx, Inc. is an biopharmaceutical company, which manufactures medical products and technologies to treat Alzheimer's disease and other Central Nervous System disorders. It is located in New York, NY. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Axonyx, Inc.
Axonyx, Inc. Pharmaceuticals: MajorHealth Technology Axonyx, Inc. is an biopharmaceutical company, which manufactures medical products and technologies to treat Alzheimer's disease and other Central Nervous System disorders. It is located in New York, NY. | Health Technology |
Hancock Rothert & Bunshoft LLP
Hancock Rothert & Bunshoft LLP Miscellaneous Commercial ServicesCommercial Services Part of Duane Morris LLP, Hancock Rothert & Bunshoft LLP is a legal advisory services provider. The private company is based in Los Angeles, CA. Hancock Rothert & Bunshoft was acquired by Duane Morris LLP on January 01, 2006. | Commercial Services |
AngioGenex, Inc.
AngioGenex, Inc. Pharmaceuticals: MajorHealth Technology AngioGenex, Inc. operates as a biopharmaceutical company, which engages in developing and commercializing novel platform of anti-proliferative drugs for the treatment of cancer and macular degeneration. The company was founded by Michael M. Strage and Robert Benezra in March 1999 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Michael M. Strage